Progress in male contraception, including male hormonal contraception, has captured the attention of mainstream media, as demonstrated by an article in the June 18 issue of Time Magazine, "This Man Wants to Be on Birth Control: Inside the race to develop a better male contraceptive." (Subscription required.) Author Alexandra Sifferlin has provided an excellent overview of the field [...]
About HDauthorThis author has not yet filled in any details.
So far HDauthor has created 16 blog entries.
Health Decisions was pleased to participate in the 2018 HealthyWomen dinner, held at the Italian Embassy in Washington June 13, where the theme was "'Alla Nostra Salute! To Our Health' - Celebrating innovation that advances women's health research and advocacy for future generations." HealthyWomen is an independent nonprofit organization addressing one of many underserved needs in [...]
Health Decisions CEO, Patrick Phillips, BSc (Hons), D.Phil., attended BIO 2018 in Boston to meet with companies active in development of new therapeutic and diagnostic products to improve healthcare outcomes for women. After the conference, Dr. Phillips offered observations on a variety of trends in evidence at the conference and on Boston as a conference [...]
Partnerships drive biopharma development today more than ever, especially in clinical development. The scope of partnerships ranges from contracts to conduct individual studies to functional-service-provider arrangements or outsourcing agreements encompassing whole development programs and sometimes even the whole of a company's clinical development activity. While clinical development partnerships are commonplace, they are seldom simple. Forming [...]
The BIO International Convention convenes June 4 in Boston, MA. The City-on-a-Hill is an excellent setting for BIO for reasons including its role as a hotbed of both academic and commercial development. As a women’s health specialty CRO, Health Decisions sees another reason to appreciate Boston as a venue for BIO: the city’s history of [...]
Health Decisions recognizes the importance of increasing the participation of women in clinical trials in order to identify differences in female response, provide female-specific prescribing information and reduce the number of adverse events experienced by women taking approved medications. Based on Health Decisions' extensive experience as a women's health specialty CRO, Project Manager Jessica Kappes, [...]
Health Decisions' Chief Medical Officer Andrea Lukes, MD, MHSc, FACOG As Health Decisions celebrates National Women’s Health Week (NWHW), we decided to sit down with our Chief Medical Officer, Andrea S. Lukes, MD, MHSc, FACOG, a practicing OB/GYN and active Principal Investigator as well as a CMO, to ask her thoughts on NWHW, key health [...]
A post in this blog during National Women's Health Week 2016 discussed six areas of significant unmet medical needs in women's health. This post for National Women's Health Week 2018 provides an update on the status of product development in addressing three of those areas of unmet need. Increased availability of noninvasive diagnostics for health conditions [...]
The Health Decisions team attending ACOG 2018 - the Annual Clinical and Scientific Meeting in Austin April 27-30 - had a busy, enjoyable and productive week with our colleagues in the OB/GYN community. In keeping with its mission as a women's health specialty CRO, Health Decisions sponsored and participated in the 5K Run/Walk for Women. [...]
Meeting planned enrollment timelines is a challenge in many clinical trials. Studies of novel products for treatment and diagnosis of women's health conditions are no exception. Based on years of experience in women's health clinical trials, the Health Decisions Clinical Affairs group has developed a methodology that has successfully accelerated start-up in studies in a [...]